Cargando…

Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial

BACKGROUND: Cutaneous leishmaniasis (CL) is treated with parenteral drugs for decades with decreasing rate cures. Miltefosine is an oral medication with anti-leishmania activity and may increase the cure rates and improve compliance. METHODOLOGY/PRINCIPAL FINDINGS: This study is a randomized, open-l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machado, Paulo R., Ampuero, Julia, Guimarães, Luiz H., Villasboas, Leonardo, Rocha, Ana T., Schriefer, Albert, Sousa, Rosana S., Talhari, Anette, Penna, Gerson, Carvalho, Edgar M.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006132/ https://www.ncbi.nlm.nih.gov/pubmed/21200420 http://dx.doi.org/10.1371/journal.pntd.0000912

Ejemplares similares

A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil
por: Machado, Paulo R L, et al.
Publicado: (2020)

Dynamics of American tegumentary leishmaniasis in a highly endemic region for Leishmania (Viannia) braziliensis infection in northeast Brazil
por: Silva, Juliana, et al.
Publicado: (2017)

Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil
por: Membrive, Norberto Assis, et al.
Publicado: (2017)

Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects
por: Guimarães, Luiz Henrique, et al.
Publicado: (2016)

Early Suppression of Macrophage Gene Expression by Leishmania braziliensis
por: Sousa, Rosana, et al.
Publicado: (2018)

Therapy of cutaneous leishmaniasis caused by Leishmania braziliensis with fluconazole
por: Veraldi, Stefano, et al.
Publicado: (2021)

The Influence of Infection by Different Leishmania (Viannia) braziliensis Isolates on the Pathogenesis of Disseminated Leishmaniasis
por: Oliveira, Walker N., et al.
Publicado: (2021)

Investigation of the pathways related to intrinsic miltefosine tolerance in Leishmania (Viannia) braziliensis clinical isolates reveals differences in drug uptake
por: Espada, Caroline R., et al.
Publicado: (2019)

Characterization of Neutrophil Function in Human Cutaneous Leishmaniasis Caused by Leishmania braziliensis
por: Conceição, Jacilara, et al.
Publicado: (2016)

Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis
por: Peixoto, Fábio, et al.
Publicado: (2020)

Outbreak of Leishmania braziliensis Cutaneous Leishmaniasis, Saül, French Guiana
por: Martin-Blondel, Guillaume, et al.
Publicado: (2015)

Clinical and histopathologic features of canine tegumentary leishmaniasis and the molecular characterization of Leishmania braziliensis in dogs
por: Lago, Jamile, et al.
Publicado: (2019)

Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil
por: dos Santos Nogueira, Fabio, et al.
Publicado: (2019)

Leishmania (Viannia) braziliensis isolated from the saliva of patients in a cutaneous leishmaniasis-endemic area of northeastern Brazil
por: de Brito, Maria Edileuza Felinto, et al.
Publicado: (2018)

Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production
por: Leopoldo, Paulo TG, et al.
Publicado: (2006)

Natural Resistance of Leishmania infantum to Miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil
por: Carnielli, Juliana B. T., et al.
Publicado: (2019)

Polymorphisms in the TOLLIP Gene Influence Susceptibility to Cutaneous Leishmaniasis Caused by Leishmania guyanensis in the Amazonas State of Brazil
por: de Araujo, Felipe Jules, et al.
Publicado: (2015)

Leishmania braziliensis causing human disease in Northeast Brazil presents loci with genotypes in long-term equilibrium
por: Silva, Juliana A., et al.
Publicado: (2022)

Chemotherapeutic Potential of 17-AAG against Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis
por: Santos, Diego M., et al.
Publicado: (2014)

Therapeutic Efficacy of Arnica in Hamsters with Cutaneous Leishmaniasis Caused by Leishmania braziliensis and L. tropica
por: Robledo, Sara M., et al.
Publicado: (2022)

Drought, Smallpox, and Emergence of Leishmania braziliensis in Northeastern Brazil
por: Sousa, Anastácio Q., et al.
Publicado: (2009)

SUCCESSFUL TREATMENT OF MULTIFOCAL CUTANEOUS LEISHMANIASIS WITH MILTEFOSINE
por: Madke, Bhushan, et al.
Publicado: (2011)

Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis
por: Castro, María del Mar, et al.
Publicado: (2017)

The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis
por: Carneiro, Pedro Paulo, et al.
Publicado: (2016)

A dysflagellar mutant of Leishmania (Viannia) braziliensis isolated from a cutaneous leishmaniasis patient
por: Zauli, Rogéria C, et al.
Publicado: (2012)

Canine Cutaneous Leishmaniasis: Dissemination and Tissue Tropism of Genetically Distinct Leishmania (Viannia) braziliensis Populations
por: de Oliveira, Guilherme Marx, et al.
Publicado: (2013)

Failure of Liposomal-amphotericin B Treatment for New World Cutaneous Leishmaniasis due to Leishmania braziliensis
por: Kosaka, Atsushi, et al.
Publicado: (2020)

Complex cutaneous infection by Leishmania mexicana treated with miltefosine
por: Sadowsky, Rachel L., et al.
Publicado: (2022)

Leishmania braziliensis isolated from disseminated leishmaniasis patients downmodulate neutrophil function
por: Cardoso, Thiago, et al.
Publicado: (2019)

Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel
por: Solomon, Michal, et al.
Publicado: (2019)

Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis
por: Giudice, Angela, et al.
Publicado: (2007)

GENOTYPE CHARACTERIZATION OF Leishmania (Viannia) braziliensis ISOLATED FROM HUMAN AND CANINE BIOPSIES WITH AMERICAN CUTANEOUS LEISHMANIASIS
por: FERREIRA, Lasaro Teixeira, et al.
Publicado: (2015)

Leishmania (Viannia) braziliensis type 2 as probable etiological agent of canine cutaneous leishmaniasis in Brazilian Amazon
por: Brilhante, Andreia Fernandes, et al.
Publicado: (2019)

Dogs Harbor Leishmania braziliensis and Participate in the Transmission Cycle of Human Tegumentary Leishmaniasis
por: Lago, Jamile, et al.
Publicado: (2023)

Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion
por: Christensen, Stephen M., et al.
Publicado: (2016)

The gp63 Gene Cluster Is Highly Polymorphic in Natural Leishmania (Viannia) braziliensis Populations, but Functional Sites Are Conserved
por: Medina, Lilian S., et al.
Publicado: (2016)

In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis
por: Coelho, Adriano C., et al.
Publicado: (2014)

Forecasting Temporal Dynamics of Cutaneous Leishmaniasis in Northeast Brazil
por: Lewnard, Joseph A., et al.
Publicado: (2014)

Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon
por: Guerra, Jorge Augusto de Oliveira, et al.
Publicado: (2011)

Leishmania braziliensis Infection Enhances Toll-Like Receptors 2 and 4 Expression and Triggers TNF-α and IL-10 Production in Human Cutaneous Leishmaniasis
por: Polari, Ludmila P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3rkvbfvebr7qavie4dn4aa9j7o